Another study containing 107 MDS patients treated by DNMTi concluded that none of the 26 analyzed MDS genes associated with the response to DNMTi, however, the TP53 and DNMT3A mutations again occurred in patients with shorter overall survival and AML-free survival [8]. Here, TP53 is linked to acute myeloid leukemia.